Income Statement

BICARA THERAPEUTICS INC.

BCAX

Performance Overview Click any row in the table to add it to this chart

in millions USD

Metric	Dec 31, 2025 2025 FY	Dec 31, 2024 2024 FY
Revenue	-	-
Cost of Revenue	-	-
Gross Profit	-	-
Operating Expenses	155.60	82.39
Research & Development	125.10	63.62
Selling, General & Administrative	30.51	18.77
Other Operating Expenses	-	-
Operating Income	-155.60	-82.39
Non-Operating Income	17.87	14.58
Interest Income	17.87	14.58
Interest Expense	-	-
Other Non-Op Income / Expense	-	-
Income Before Tax	-137.73	-67.81
Income Tax Expense	0.22	0.19
Non-Controlling Interest	-	-
Net Income	-137.95	-68.00

Supplemental Per share data, derived & other items — not part of the income statement

in millions USD unless noted